Cargando…

What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities

BACKGROUND: Successful implementation can increase the availability of evidence-based treatments but continued patient access can be threatened if there is not deliberate focus on sustainment. Real-world examples are needed to elucidate contributors to sustainability. OBJECTIVE: We examined sustaina...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackland, Princess E., Kenny, Marie E., Clothier, Barbara A., Salameh, Hope A., Boening, Natassia, Gordon, Adam J., Noorbaloochi, Siamak, Gustavson, Allison M., Miller, Wendy, Hagedorn, Hildi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088728/
https://www.ncbi.nlm.nih.gov/pubmed/37037986
http://dx.doi.org/10.1007/s11606-023-08116-4
_version_ 1785022625284620288
author Ackland, Princess E.
Kenny, Marie E.
Clothier, Barbara A.
Salameh, Hope A.
Boening, Natassia
Gordon, Adam J.
Noorbaloochi, Siamak
Gustavson, Allison M.
Miller, Wendy
Hagedorn, Hildi J.
author_facet Ackland, Princess E.
Kenny, Marie E.
Clothier, Barbara A.
Salameh, Hope A.
Boening, Natassia
Gordon, Adam J.
Noorbaloochi, Siamak
Gustavson, Allison M.
Miller, Wendy
Hagedorn, Hildi J.
author_sort Ackland, Princess E.
collection PubMed
description BACKGROUND: Successful implementation can increase the availability of evidence-based treatments but continued patient access can be threatened if there is not deliberate focus on sustainment. Real-world examples are needed to elucidate contributors to sustainability. OBJECTIVE: We examined sustainability of outcomes of a study which tested a 12-month external facilitation intervention. The study evaluated change in access to medications for opioid use disorder (MOUD) in Veterans Health Administration (VHA) facilities in the lowest quartile of MOUD prescribing. DESIGN: Convergent mixed-methods design. PARTICIPANTS: Thirty-nine providers and leaders from eight VHA facilities. APPROACH: Thirty-minute post-implementation telephone interviews explored whether barriers identified pre-implementation were successfully addressed, the presence of any new challenges, helpfulness of external facilitation, and plans for sustaining MOUD access. Interviews were analyzed using a rapid turn-around approach. VHA administrative data were used to characterize the facilities and assess their ratio of patients with an OUD diagnosis receiving MOUD (MOUD/OUD ratio) at the end of a 9-month sustainability period. KEY RESULTS: Commonly reported contributors to sustained MOUD access included national attention on the opioid epidemic, accountability created by study participation, culture shift in MOUD acceptability, leadership support, and plans to build on initial progress. Frequently reported barriers included staffing issues and lack of MOUD-devoted time; the need to overhaul existing policies, practices, and/or processes; and fear and anxiety about MOUD prescribing. All facilities either maintained MOUD/OUD ratio improvement (n = 2) or further improved (n = 6) at the end of sustainability. Facilities with the highest and lowest ratio at the end of sustainability used a team-based approach to MOUD delivery; however, organizational setting differences may have impacted overall MOUD access. CONCLUSIONS: Ensuring stable and consistent staff, and sufficient time dedicated to MOUD are critical to sustaining access to evidence-based treatment in low-adopting facilities. This study highlights the importance of investing in local, system-level changes to improve and sustain access to effective treatments.
format Online
Article
Text
id pubmed-10088728
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100887282023-04-12 What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities Ackland, Princess E. Kenny, Marie E. Clothier, Barbara A. Salameh, Hope A. Boening, Natassia Gordon, Adam J. Noorbaloochi, Siamak Gustavson, Allison M. Miller, Wendy Hagedorn, Hildi J. J Gen Intern Med Original Research: Qualitative Research BACKGROUND: Successful implementation can increase the availability of evidence-based treatments but continued patient access can be threatened if there is not deliberate focus on sustainment. Real-world examples are needed to elucidate contributors to sustainability. OBJECTIVE: We examined sustainability of outcomes of a study which tested a 12-month external facilitation intervention. The study evaluated change in access to medications for opioid use disorder (MOUD) in Veterans Health Administration (VHA) facilities in the lowest quartile of MOUD prescribing. DESIGN: Convergent mixed-methods design. PARTICIPANTS: Thirty-nine providers and leaders from eight VHA facilities. APPROACH: Thirty-minute post-implementation telephone interviews explored whether barriers identified pre-implementation were successfully addressed, the presence of any new challenges, helpfulness of external facilitation, and plans for sustaining MOUD access. Interviews were analyzed using a rapid turn-around approach. VHA administrative data were used to characterize the facilities and assess their ratio of patients with an OUD diagnosis receiving MOUD (MOUD/OUD ratio) at the end of a 9-month sustainability period. KEY RESULTS: Commonly reported contributors to sustained MOUD access included national attention on the opioid epidemic, accountability created by study participation, culture shift in MOUD acceptability, leadership support, and plans to build on initial progress. Frequently reported barriers included staffing issues and lack of MOUD-devoted time; the need to overhaul existing policies, practices, and/or processes; and fear and anxiety about MOUD prescribing. All facilities either maintained MOUD/OUD ratio improvement (n = 2) or further improved (n = 6) at the end of sustainability. Facilities with the highest and lowest ratio at the end of sustainability used a team-based approach to MOUD delivery; however, organizational setting differences may have impacted overall MOUD access. CONCLUSIONS: Ensuring stable and consistent staff, and sufficient time dedicated to MOUD are critical to sustaining access to evidence-based treatment in low-adopting facilities. This study highlights the importance of investing in local, system-level changes to improve and sustain access to effective treatments. Springer International Publishing 2023-04-10 2023-09 /pmc/articles/PMC10088728/ /pubmed/37037986 http://dx.doi.org/10.1007/s11606-023-08116-4 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023
spellingShingle Original Research: Qualitative Research
Ackland, Princess E.
Kenny, Marie E.
Clothier, Barbara A.
Salameh, Hope A.
Boening, Natassia
Gordon, Adam J.
Noorbaloochi, Siamak
Gustavson, Allison M.
Miller, Wendy
Hagedorn, Hildi J.
What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title_full What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title_fullStr What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title_full_unstemmed What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title_short What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities
title_sort what contributes to sustainability? examining access to medications for opioid use disorder in low-adopting vha facilities
topic Original Research: Qualitative Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088728/
https://www.ncbi.nlm.nih.gov/pubmed/37037986
http://dx.doi.org/10.1007/s11606-023-08116-4
work_keys_str_mv AT acklandprincesse whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT kennymariee whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT clothierbarbaraa whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT salamehhopea whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT boeningnatassia whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT gordonadamj whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT noorbaloochisiamak whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT gustavsonallisonm whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT millerwendy whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities
AT hagedornhildij whatcontributestosustainabilityexaminingaccesstomedicationsforopioidusedisorderinlowadoptingvhafacilities